These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 28119431)

  • 1. EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma-Induced Epigenetic Suppression of Osteoblast Differentiation.
    Adamik J; Jin S; Sun Q; Zhang P; Weiss KR; Anderson JL; Silbermann R; Roodman GD; Galson DL
    Mol Cancer Res; 2017 Apr; 15(4):405-417. PubMed ID: 28119431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the
    Adamik J; Silbermann R; Marino S; Sun Q; Anderson JL; Zhou D; Xie XQ; Roodman GD; Galson DL
    Front Endocrinol (Lausanne); 2018; 9():344. PubMed ID: 30008697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease.
    D'Souza S; del Prete D; Jin S; Sun Q; Huston AJ; Kostov FE; Sammut B; Hong CS; Anderson JL; Patrene KD; Yu S; Velu CS; Xiao G; Grimes HL; Roodman GD; Galson DL
    Blood; 2011 Dec; 118(26):6871-80. PubMed ID: 22042697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.
    Tong ZT; Cai MY; Wang XG; Kong LL; Mai SJ; Liu YH; Zhang HB; Liao YJ; Zheng F; Zhu W; Liu TH; Bian XW; Guan XY; Lin MC; Zeng MS; Zeng YX; Kung HF; Xie D
    Oncogene; 2012 Feb; 31(5):583-94. PubMed ID: 21685935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Signatures at the RUNX2-P1 and Sp7 Gene Promoters Control Osteogenic Lineage Commitment of Umbilical Cord-Derived Mesenchymal Stem Cells.
    Sepulveda H; Aguilar R; Prieto CP; Bustos F; Aedo S; Lattus J; van Zundert B; Palma V; Montecino M
    J Cell Physiol; 2017 Sep; 232(9):2519-2527. PubMed ID: 27689934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition.
    Rizq O; Mimura N; Oshima M; Saraya A; Koide S; Kato Y; Aoyama K; Nakajima-Takagi Y; Wang C; Chiba T; Ma A; Jin J; Iseki T; Nakaseko C; Iwama A
    Clin Cancer Res; 2017 Aug; 23(16):4817-4830. PubMed ID: 28490465
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2.
    Dudakovic A; Samsonraj RM; Paradise CR; Galeano-Garces C; Mol MO; Galeano-Garces D; Zan P; Galvan ML; Hevesi M; Pichurin O; Thaler R; Begun DL; Kloen P; Karperien M; Larson AN; Westendorf JJ; Cool SM; van Wijnen AJ
    J Biol Chem; 2020 Jun; 295(23):7877-7893. PubMed ID: 32332097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1.
    Duan Z; Zarebski A; Montoya-Durango D; Grimes HL; Horwitz M
    Mol Cell Biol; 2005 Dec; 25(23):10338-51. PubMed ID: 16287849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner.
    Jensen ED; Schroeder TM; Bailey J; Gopalakrishnan R; Westendorf JJ
    J Bone Miner Res; 2008 Mar; 23(3):361-72. PubMed ID: 17997710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of HDAC1 by miR-449a upregulates Runx2 and promotes osteoblast differentiation.
    Liu T; Hou L; Zhao Y; Huang Y
    Int J Mol Med; 2015 Jan; 35(1):238-46. PubMed ID: 25405810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation.
    Giuliani N; Colla S; Morandi F; Lazzaretti M; Sala R; Bonomini S; Grano M; Colucci S; Svaldi M; Rizzoli V
    Blood; 2005 Oct; 106(7):2472-83. PubMed ID: 15933061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAP Kinase-Dependent RUNX2 Phosphorylation Is Necessary for Epigenetic Modification of Chromatin During Osteoblast Differentiation.
    Li Y; Ge C; Franceschi RT
    J Cell Physiol; 2017 Sep; 232(9):2427-2435. PubMed ID: 27514023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Control of the Bone-master Runx2 Gene during Osteoblast-lineage Commitment by the Histone Demethylase JARID1B/KDM5B.
    Rojas A; Aguilar R; Henriquez B; Lian JB; Stein JL; Stein GS; van Wijnen AJ; van Zundert B; Allende ML; Montecino M
    J Biol Chem; 2015 Nov; 290(47):28329-28342. PubMed ID: 26453309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC1,2 inhibition impairs EZH2- and BBAP-mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma.
    Johnson DP; Spitz GS; Tharkar S; Quayle SN; Shearstone JR; Jones S; McDowell ME; Wellman H; Tyler JK; Cairns BR; Chandrasekharan MB; Bhaskara S
    Oncotarget; 2015 Mar; 6(7):4863-87. PubMed ID: 25605023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mll-COMPASS complexes mediate H3K4me3 enrichment and transcription of the osteoblast master gene Runx2/p57 in osteoblasts.
    Rojas A; Sepulveda H; Henriquez B; Aguilar R; Opazo T; Nardocci G; Bustos F; Lian JB; Stein JL; Stein GS; van Zundert B; van Wijnen AJ; Allende ML; Montecino M
    J Cell Physiol; 2019 May; 234(5):6244-6253. PubMed ID: 30256410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression.
    Zhu L; Xu PC
    Biochem Biophys Res Commun; 2013 Mar; 432(4):612-7. PubMed ID: 23438432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of LncRNA-ANCR Promotes the Osteogenesis of Osteoblast Cells in Postmenopausal Osteoporosis via Targeting EZH2 and RUNX2.
    Cai N; Li C; Wang F
    Yonsei Med J; 2019 Aug; 60(8):751-759. PubMed ID: 31347330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation.
    Schroeder TM; Kahler RA; Li X; Westendorf JJ
    J Biol Chem; 2004 Oct; 279(40):41998-2007. PubMed ID: 15292260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression.
    Fan T; Jiang S; Chung N; Alikhan A; Ni C; Lee CC; Hornyak TJ
    Mol Cancer Res; 2011 Apr; 9(4):418-29. PubMed ID: 21383005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.
    Alzrigat M; Párraga AA; Agarwal P; Zureigat H; Österborg A; Nahi H; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H
    Oncotarget; 2017 Feb; 8(6):10213-10224. PubMed ID: 28052011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.